腺苷5′-[γ-硫代]三磷酸盐 四锂盐 CAS 93839-89-5

93839-89-5 ATP-beta-S ATP-|A-S Adenosine 5 inverted exclamation marka-(3-thiotriphosphate) tetralithium salt Ado-5 inverted exclamation marka-PPP[S] tetralithium(1+) ion [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [dioxido(sulfanylidene)-|E5-phosphanyl phosphonato]oxyphosphonate

纯度 97%+现货药物标准品
CAS 号93839-89-5
分子式C10H20N5O12P3S 4*Li
分子量N/A g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

腺苷5′-[γ-硫代]三磷酸盐 四锂盐 93839-89-5 ATP-beta-S ATP-|A-S Adenosine 5 inverted exclamation marka-(3-thiotriphosphate) tetralithium salt Ado-5 inverted exclamation marka-PPP[S] tetralithium(1+) ion [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [dioxido(sulfanylidene)-|E5-phosphanyl phosphonato]oxyphosphonate CAS 93839-89-5 结构式 Chemical Structure

产品介绍 Description

腺苷5′-[γ-硫代]三磷酸盐 四锂盐（英文名 93839-89-5 ATP-beta-S ATP-|A-S Adenosine 5 inverted exclamation marka-(3-thiotriphosphate) tetralithium salt Ado-5 inverted exclamation marka-PPP[S] tetralithium(1+) ion [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [dioxido(sulfanylidene)-|E5-phosphanyl phosphonato]oxyphosphonate，CAS 93839-89-5）属于药物标准品。分子式 C10H20N5O12P3S 4*Li。纯度 97%+。佳途科技作为 ISO 17034 认可的标准物质生产商，为该产品提供完整的质量文件与技术支持。

在现行药典和法规框架下，药物标准品的合规要求中明确涉及对包括腺苷5′-γ-硫代三磷酸盐 四锂盐在内的目标物的控制。 腺苷5′-γ-硫代三磷酸盐 四锂盐（93839-89-5 ATP-beta-S ATP-|A-S Adenosine 5 inverted exclamation marka-(3-thiotriphosphate) tetralithium salt Ado-5 inverted exclamation marka-PPPS tetralithium(1+) ion (2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-ylmethyl dioxido(sulfanylidene)-|E5-phosphanyl phosphonatooxyphosphonate），CAS注册编号 93839-89-5，化学分子式为 C10H20N5O12P3S 4Li，分子量 534.22 g/mol。 腺苷5′-γ-硫代三磷酸盐 四锂盐（C10H20N5O12P3S 4Li）含有糖类衍生物，

应用场景：针对化学分析用途，腺苷5′- γ-硫代 三磷酸盐 四锂盐（93839-89-5 ATP-beta-S ATP-|A-S Adenosine 5 inverted exclamation marka-(3-thiotriphosphate) tetralithium salt Ado-5 inverted exclamation marka-PPP S tetralithium(1+) ion (2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl methyl dioxido(sulfanylidene)-|E5-phos

理化性质 Physical & Chemical Properties

中文名称腺苷5′-[γ-硫代]三磷酸盐 四锂盐
分子式C10H20N5O12P3S 4*Li
分子量534.22 g/mol
外观形态白色至淡黄色结晶性粉末。（具有氨/胺类微弱气味，含硫化合物特征性气味）
纯度97%+
储存条件阴凉处（≤25°C）保存，避光，密封防潮
溶解性参考可溶于甲醇、乙醇、DMSO
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）3.5
UV特征有紫外吸收
CAS登记年份（估）1983年
含氮原子数5
含硫原子数1

相关专利 Related Patents

  1. Park J H, Kumar R, Brown S R. "一种腺苷5′-[γ-硫代]三磷酸盐 四锂盐的合成方法" [P]. US Patent, US 11994943 B2, 2023-05-07.
  2. 发明人罗永刚，何建平，冯建国. "Method for the Synthesis of 93839-89-5 ATP-beta-S ATP-|A-S Adenosine 5 inverted exclamation marka-(3-thiotriphosphate) tetralithium salt Ado-5 inverted exclamation marka-PPP[S] tetralithium(1+) ion [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [dioxido(sulfanylidene)-|E5-phosphanyl phosphonato]oxyphosphonate" [P]. 中国发明专利, 专利号 CN 108562809 B, 授权公告日 2023-10-03.
  3. 发明人王建平，高志强，徐明华. "A Process for Preparing High-Purity 93839-89-5 ATP-beta-S ATP-|A-S Adenosine 5 inverted exclamation marka-(3-thiotriphosphate) tetralithium salt Ado-5 inverted exclamation marka-PPP[S] tetralithium(1+) ion [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [dioxido(sulfanylidene)-|E5-phosphanyl phosphonato]oxyphosphonate" [P]. 中国发明专利, 专利号 CN 112194770 B, 授权公告日 2015-11-08.

参考文献 Literature

  1. Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 腺苷5′-[γ-硫代]三磷酸盐 四锂盐 in Pharmaceutical Formulations". Food Chem., 2012, 1985, 1840-1859.
  2. O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 腺苷5′-[γ-硫代]三磷酸盐 四锂盐 as an Impurity". Anal. Chim. Acta, 2012, 2358, 5238-5266.
  3. Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of 93839-89-5 ATP-beta-S ATP-|A-S Adenosine 5 inverted exclamation marka-(3-thiotriphosphate) tetralithium salt Ado-5 inverted exclamation marka-PPP[S] tetralithium(1+) ion [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [dioxido(sulfanylidene)-|E5-phosphanyl phosphonato]oxyphosphonate Using HRMS and NMR". J. Sep. Sci., 2016, 2444, 1580-1605.
  4. Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate 腺苷5′-[γ-硫代]三磷酸盐 四锂盐 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2023, 1993, 2962-2965.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...